Literature DB >> 23604280

[Generalised erythema, scaling and hair anomaly].

C Hammer1, N Voshege, U Hillen, J Dissemond.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23604280     DOI： 10.1007/s00105-013-2582-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  5 in total

1.  Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome.

Authors:  Pascal Descargues; Céline Deraison; Catherine Prost; Sylvie Fraitag; Juliette Mazereeuw-Hautier; Marina D'Alessio; Akemi Ishida-Yamamoto; Christine Bodemer; Giovanna Zambruno; Alain Hovnanian
Journal:  J Invest Dermatol       Date:  2006-04-20       Impact factor: 8.551

2.  Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin.

Authors:  Lionel Fontao; Emmanuel Laffitte; Anais Briot; Gürkan Kaya; Pascale Roux-Lombard; Sylvie Fraitag; Alain A Hovnanian; Jean-Hilaire Saurat
Journal:  J Invest Dermatol       Date:  2011-06-09       Impact factor: 8.551

3.  Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.

Authors:  Jean-Pierre Hachem; Fredrik Wagberg; Matthias Schmuth; Debra Crumrine; Willy Lissens; Arumugam Jayakumar; Evi Houben; Theodora M Mauro; Göran Leonardsson; Maria Brattsand; Torbjorn Egelrud; Diane Roseeuw; Gary L Clayman; Kenneth R Feingold; Mary L Williams; Peter M Elias
Journal:  J Invest Dermatol       Date:  2006-04-06       Impact factor: 8.551

4.  Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.

Authors:  Nahoko Komatsu; Kiyofumi Saijoh; Arumugam Jayakumar; Gary L Clayman; Mikiko Tohyama; Yasushi Suga; Yuki Mizuno; Katsuhiko Tsukamoto; Katsushige Taniuchi; Kazuhiko Takehara; Eleftherios P Diamandis
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

Review 5.  Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings.

Authors:  Ghada Bin Saif; Sultan Al-Khenaizan
Journal:  Int J Dermatol       Date:  2007-03       Impact factor: 2.736
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.